Skip to main content
Science|Business

Bringing together industry, research and policy

Menu
  • News
    • Funding Newswire
    • The Widening
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Latest updates
    • Why Join?
    • Testimonials
    • Become a member
    • The Widening
    • Network news
  • Communications Services
    • Overview
    • Strategic advice
    • Campaigns
    • Events
    • Reports
    • Sponsorships
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers

Galapagos NV

VIB, CD3 and Galapagos NV enter license deal for the development of MALT1 inhibitors

VIB, CD3 and Galapagos NV enter license deal for the development of MALT1 inhibitors

10 Jan 2018
Health

Morphosys and Galapagos team up on musculoskeletal diseases

03 Dec 2008
Health

Galapagos lands €5.2M in grants for drug development

16 Oct 2007
News

Galapagos: five-year agreement with US EPA

24 Apr 2007
News

Galapagos acquires UCL spin out in €12.5M all-share deal

Galapagos NV is bolstering its ability to select drug targets and compounds by acquiring Inpharmatica Ltd in an all-share transaction that values the UK bioinformatics company at €12.5 million.
12 Dec 2006
News
Subscribe to Galapagos NV

Get the Science|Business newsletters

newsletter iconReceive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 

  Sign up for the Funding Newswire

  Sign up for the Policy Bulletin

  Sign up for The Widening

Funding Newswire subscription

align-right

Follow where the public and private R&I money is going and which collaborative opportunities you can pursue. 

Subscribe today

Log in

Find out more about the Science|Business Network

Network iconA unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.

  Why join?

  Become a member

Jobs

Eureka is looking for a Clusters Coordinator
Eureka is looking for a Data Coordinator & Analyst
Home

Privacy   |   T&Cs   |   © 2025 Science Business Publishing Ltd.

  • News
    • Funding Newswire
    • The Widening
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Latest updates
    • Why Join?
    • Testimonials
    • Become a member
    • The Widening
    • Network news
  • Communications Services
    • Overview
    • Strategic advice
    • Campaigns
    • Events
    • Reports
    • Sponsorships
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers